COVID: Spallanzani to start double Sputnik V experimentation

Effectiveness on variants, use in combination with other jabs

(ANSA) - ROME, MAR 26 - Rome's Spallanzani infectious-diseases hospital will start experimentation on the Sputnik V COVID-19 vaccine in collaboration with Russia's Gamaleya Institute after Easter, sources said Friday.
    The research will go in two directions, the sources said.
    One line of experimentation will focus on the effectiveness of Sputnik V against new COVID strains, especially the Brazilian, South African and British variants, the sources said.
    The other will look at the giving Sputnik V as a second dose on people who have had the first doses of a vaccine with a similar structure, such as the AstraZeneca one, the sources said.
    The Gamaleya Institute will provide 100 doses for the first phase of testing. (ANSA).


Change cookie consent